DiscoverLeaders & LegendsInnovation and Risk in Pharma: John Hubbard, Strategic Healthcare Advisor, Board Member and Chairman
Innovation and Risk in Pharma: John Hubbard, Strategic Healthcare Advisor, Board Member and Chairman

Innovation and Risk in Pharma: John Hubbard, Strategic Healthcare Advisor, Board Member and Chairman

Update: 2025-06-27
Share

Description

Patty sits down with John Hubbard, Strategic Healthcare Advisor, Board Member, and former CEO and President of multiple organizations across pharma and CROs. John shares a candid perspective on why the clinical trials industry continues to struggle with change adoption and innovation.

From leading large-scale transformations at Pfizer to driving industry-wide collaboration through initiatives like TransCelerate, John reflects on the cultural and structural barriers that make progress difficult. He also offers advice to entrepreneurs and innovators trying to break through and why real change often takes a combination of vision, resilience, and a willingness to challenge the status quo.

Comments 
loading
In Channel
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Innovation and Risk in Pharma: John Hubbard, Strategic Healthcare Advisor, Board Member and Chairman

Innovation and Risk in Pharma: John Hubbard, Strategic Healthcare Advisor, Board Member and Chairman

Diligent Pharma